Dr. Ryerson’s research focuses on the diagnosis, management, and prognostication of pulmonary fibrosis. This includes recent work on frailty and body composition as well as several studies exploring the benefits of oxygen supplementation in patients with pulmonary fibrosis and optimal strategies for its use. Dr. Ryerson leads the Canadian Registry for Pulmonary Fibrosis (CARE-PF), an 8-centre prospective registry that is among the largest in the world, as well as the HOPE-IPF study, which is a randomized controlled trial evaluating the clinical and physiological impact of oxygen supplementation during exercise training in patients with idiopathic pulmonary fibrosis. Dr. Ryerson has also been involved in several national and international clinical practice guidelines on the diagnosis and management of pulmonary fibrosis.